XML 84 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 6 Months Ended 12 Months Ended
Sep. 23, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Jun. 30, 2020
Jun. 30, 2019
Dec. 05, 2012
Share-based Compensation [Line Items]              
Options granted (shares)       0 0 0  
Unrecognized stock-based compensation expense   $ 61.7   $ 61.7      
Weighted-average period for recognition (years)       2 years 3 months 18 days      
2017 Plan              
Share-based Compensation [Line Items]              
Number of shares authorized   4,600,000   4,600,000      
Shares available for grant   3,600,000   3,600,000      
2012 Purchase Plan              
Share-based Compensation [Line Items]              
Number of shares authorized             2,000,000
Additional shares available for future grant 2,000,000            
Maximum number of shares per participant per offering period 5,000            
Shares issued under the Plan   2,000,000          
President and Chief Executive Officer              
Share-based Compensation [Line Items]              
Options granted (shares)     700,000        
Weighted average grant date fair value of options granted (dollars per share)     $ 13.38        
Options and RSUs | Non-employee director              
Share-based Compensation [Line Items]              
Service period for award vesting (in years)       1 year      
Stock options              
Share-based Compensation [Line Items]              
Service period for award vesting (in years)       4 years      
Award expiration period (in years)       10 years      
Stock options | President and Chief Executive Officer              
Share-based Compensation [Line Items]              
Award expiration period (in years)       7 years      
RSUs              
Share-based Compensation [Line Items]              
Service period for award vesting (in years)       4 years      
Weighted average grant date fair value (dollars per share)     $ 13.69 $ 29.83 $ 27.96 $ 46.62  
Fair value of restricted stock units that vested     $ 29.1 $ 22.6 $ 32.4 $ 27.6  
RSUs | Certain executive officers and other senior positions | Achievement levels based on EPS targets              
Share-based Compensation [Line Items]              
Vesting weight (percent)       50.00%      
RSUs | Certain executive officers and other senior positions | Performance based on Nasdaq Healthcare Provider Index              
Share-based Compensation [Line Items]              
Vesting weight (percent)       50.00%